From a general perspective, the ECS affects food intake and energy metabolism; for instance, pharmacological inhibition of CB1 by SR141716 (Rimonabant) reversed the obesity complications in rodents and improved several metabolic processes [19, 20]. The gene discussed is CNR1; the disease is obesity disorder.